CMNZX
Price
$18.76
Change
-$0.05 (-0.27%)
Updated
Jun 6 closing price
Net Assets
475.07M
FMNQX
Price
$10.78
Change
-$0.03 (-0.28%)
Updated
Jun 6 closing price
Net Assets
618.39M
Interact to see
Advertisement

CMNZX vs FMNQX

Header iconCMNZX vs FMNQX Comparison
Open Charts CMNZX vs FMNQXBanner chart's image
Columbia Minnesota Tax-Exempt Inst
Price$18.76
Change-$0.05 (-0.27%)
VolumeN/A
Net Assets475.07M
Franklin MN Tax-Free Inc A
Price$10.78
Change-$0.03 (-0.28%)
VolumeN/A
Net Assets618.39M
CMNZX vs FMNQX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CMNZX vs. FMNQX commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMNZX is a Hold and FMNQX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FMNQX has more cash in the bank: 618M vs. CMNZX (475M). CMNZX pays higher dividends than FMNQX: CMNZX (3.52) vs FMNQX (3.07). CMNZX was incepted earlier than FMNQX: CMNZX (15 years) vs FMNQX (7 years). FMNQX (0.84) is less costly to investors than CMNZX (0.56). CMNZX is a more actively managed with annual turnover of: 10.00 vs. FMNQX (4.25). FMNQX has a lower initial minimum investment than CMNZX: FMNQX (1000) vs CMNZX (2000). FMNQX annual gain was more profitable for investors over the last year : 0.25 vs. CMNZX (0.16). CMNZX return over 5 years is better than : -1.20 vs. FMNQX (-6.77).
CMNZXFMNQXCMNZX / FMNQX
Total Expense Ratio0.560.8467%
Annual Report Gross Expense Ratio0.560.8467%
Fund Existence15 years7 years-
Gain YTD-2.398-1.890127%
Front LoadN/A4%-
Min. Initial Investment20001000200%
Min. Initial Investment IRAN/AN/A-
Net Assets475M618M77%
Annual Yield % from dividends3.523.07115%
Returns for 1 year0.160.2564%
Returns for 3 years2.371.16204%
Returns for 5 years-1.20-6.7718%
Returns for 10 years14.18N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATXS5.990.77
+14.75%
Astria Therapeutics
CNTB0.790.01
+1.46%
Connect Biopharma Holdings Limited
MLNK17.060.20
+1.19%
MeridianLink
CPRT50.13-0.01
-0.02%
Copart
NUVL78.02-0.07
-0.09%
Nuvalent